"The official opening of our new headquarters marks an exciting milestone in our Welch's journey," said Trevor Bynum, President and Chief Executive Officer of Welch's and National Grape Cooperative. "As we enter our next phase of growth, this new space in the dynamic business community of Waltham provides the ideal environment for our teams to thrive and reach our ambitious goals." A grand opening and ribbon-cutting ceremony was held on June 17 to celebrate the occasion, featuring inspiring remarks from Byn ...

科创板第五套上市标准跟随整个IPO市场收紧于2023年8月，2024年"科创板八条"、2025年全国两会均释放政策转向信号，在2025年陆家嘴论坛上 正式重启 文｜《财经》记者 张欣培 编辑 | 郭楠 陆玲 6月18日，在2025陆家嘴论坛上，证监会主席吴清在致辞中总结了中国资本市场发生的深刻结构性变化，并公布了推动科技创新和产业创新融合发 展的一系列重要举措。 吴清表示，推动科技创新和产业创新融合发展，需要更好发挥资本市场枢纽功能。在新的形势下，构建以资本市场为枢纽的创新生态、提升创新 资本形成效率，对于加快科技创新和产业创新融合发展意义重大。 实际上，经过近几年的发展，中国资本市场已经发生了深刻的结构性变化。吴清总结，一方面，中国证监会认真落实创新驱动发展战略，引导各 类要素资源加快向创新领域集聚，为支持科技创新和产业转型升级提供了重要支撑；另一方面，资本市场在有力服务科技创新和产业转型升级过 程中，也反过来促进了自身结构、效率和投资价值的不断改善，为强本强基、高质量发展注入了源头活水。 为加快构建更有利于支持全面创新的资本市场生态，吴清在论坛上透露，将推出科创板进一步深化改革的"1+6"政策措施。"1" ...

2025年7月9日，是越南的"生死线"——若不能与美国达成协议，越南对美出口的纺织、电子等支柱产业将面临46%的"灭顶关税"。 但妥协的代价触目惊心：协议签署次日，美国突然将越南钢铁关税跳涨至50%，当地铝企订单一夜蒸发30%。越南纺织协会副会长陈如 松哀叹："60%面料依赖中国，强行切割等于自断经脉！" 当越南被迫"关门"，中国企业已悄然突围。光伏龙头在越南建硅料厂，但核心技术专利仍牢牢握在中国总部手中，"越南制造"实为"中国 大脑"。电子厂则将最后组装工序转至柬埔寨，利用东盟内部免税政策曲线进入美国市场。 这场谈判背后，藏着美国对中国供应链的精准绞杀：越南被迫签下"投名状"，用封堵中国转口贸易的代价，换取关税从46%降至 20%-25%。但代价有多大？越南工贸部的数据显示，2024年越南对美1235亿美元顺差中，12%来自中国商品"借道"出口，如今这条"黄金 通道"被一刀斩断，全球供应链格局正在崩塌重组。 美国对越南的让步，实为针对中国的一箭双雕。 第一招是数据铁幕：越南海关系统被强制接入美国溯源数据库，光伏板、锂电池等敏感商品从原材料到成品的物流信息，实时同步给美 国海关。这意味着，即便一颗中国螺丝钉在 ...

公司股价与估值 - 6月18日收盘价21.01元，下跌1.22%，总市值101.15亿元 [1] - 滚动市盈率19.00倍，静态市盈率18.01倍，市净率1.79倍 [1][2] - 市盈率显著低于行业平均49.10倍和行业中值36.43倍 [1][2] 行业对比 - 医疗器械行业平均总市值105.10亿，中值48.92亿 [2] - 在可比公司中市盈率排名靠后，低于三鑫医疗(18.28倍)、安杰思(17.38倍)等 [2] - 总市值位列行业第13位，低于英科医疗(151.03亿)、九安医疗(170.79亿)等头部企业 [2] 机构持仓 - 2025年一季报显示9家机构持仓，包括4家基金和5家其他机构 [1] - 合计持股8110.00万股，持股市值18.73亿元 [1] 财务表现 - 2025年一季度营收8.00亿元，同比下滑7.06% [2] - 净利润1.89亿元，同比下降13.37% [2] - 销售毛利率保持较高水平达66.67% [2] 公司业务 - 主营业务为快速诊断试剂及配套仪器的研发生产 [1] - 产品涵盖传染病检测、慢性疾病检测、妊娠及优生优育检测、毒品检测 [1] - 拥有POCT领域唯一的国家级工程实验室 [1] 企业资质 - 获得国家级"绿色工厂"称号(2025年1月) [1] - 拥有国家认定企业技术中心、博士后科研工作站等资质 [1] - 国内首批通过美国FDA现场审核的体外诊断试剂企业 [1]

QuidelOrtho (QDEL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate. Since a changing earnings pictur ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. Eve ...

Grocery Outlet Holding Corp. (GO) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years. The ...

NovoCure (NVCR) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system. Individu ...

Carnival (CCL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years. Most Powerful Force Im ...

European Wax Center, Inc. (EWCZ) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by ...